AccutarBio researchers have a number of papers on the arXiv pre-print server and recently they received $15 million in funding (including money from Chinese AI/facial recognition company YITU) while they now partner with Amgen. 1
This technology is also very well suited for the design of vaccines for infectious diseases. 1

Requests left for this source (Medium): 5